πŸ‡ΊπŸ‡Έ FDA
Patent

US 11207211

Lacrimal drug delivery device

granted A61KA61K45/00A61K9/0051

Quick answer

US patent 11207211 (Lacrimal drug delivery device) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K45/00, A61K9/0051, A61P, A61P27/02